Cargando…

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is considered a critical hepatic manifestation of metabolic syndrome. Berberine (BBR) exerts anti-hyperglycemic and anti-dyslipidemic effects and can also ameliorate NAFLD. Thus, BBR might exert its therapeutic effect on NAFLD by improving glucoli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Li, Cang, Zhen, Sun, Honglin, Nie, Xiaomin, Wang, Ningjian, Lu, Yingli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329945/ https://www.ncbi.nlm.nih.gov/pubmed/28241817 http://dx.doi.org/10.1186/s12902-017-0165-7

Ejemplares similares

Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats
por: Sun, Honglin, et al.
Publicado: (2017)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
por: Chang, Xinxia, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study
por: Yu, Yuetian, et al.
Publicado: (2023)

The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
por: Zhu, Xiaopeng, et al.
Publicado: (2016)

The associations of total testosterone with probable nonalcoholic steatohepatitis and nonalcoholic fatty liver disease fibrotic progression in men with type 2 diabetes: a cross-sectional study
por: Zhang, Ziteng, et al.
Publicado: (2022)

Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis
por: Wang, Ningjian, et al.
Publicado: (2018)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
por: Chen, Ping, et al.
Publicado: (2021)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis
por: Wei, Xiaoyun, et al.
Publicado: (2016)

Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats
por: Li, Donghao, et al.
Publicado: (2017)

Lead Exposure Induces Weight Gain in Adult Rats, Accompanied by DNA Hypermethylation
por: Sun, Honglin, et al.
Publicado: (2017)

Blood lead level is associated with non-alcoholic fatty liver disease in the Yangtze River Delta region of China in the context of rapid urbanization
por: Zhai, Hualing, et al.
Publicado: (2017)

Diospyros kaki and Citrus unshiu Mixture Improves Disorders of Lipid Metabolism in Nonalcoholic Fatty Liver Disease
por: Shin, Mi-Rae, et al.
Publicado: (2020)

Bone Turnover Markers and Probable Advanced Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Men and Postmenopausal Women With Type 2 Diabetes
por: Wang, Ningjian, et al.
Publicado: (2020)

Combined Association of Vitamin D and Sex Hormone Binding Globulin With Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women: A Cross-Sectional Study
por: Wang, Ningjian, et al.
Publicado: (2016)

Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
por: Ma, Yuting, et al.
Publicado: (2021)

PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease
por: Rana, Rajashree, et al.
Publicado: (2019)

Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013)

Metabolic Targets in Nonalcoholic Fatty Liver Disease
por: Esler, William P., et al.
Publicado: (2019)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023)

Neck circumference as an independent indicator to non-alcoholic fatty liver disease in non-obese men
por: Li, Qin, et al.
Publicado: (2015)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease
por: Hall, Zoe, et al.
Publicado: (2017)

The Influence of Metabolic Factors for Nonalcoholic Fatty Liver Disease in Women
por: Chung, Goh Eun, et al.
Publicado: (2015)

Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease
por: Pan, Xiongfeng, et al.
Publicado: (2021)

Identification and immunological characterization of lipid metabolism-related molecular clusters in nonalcoholic fatty liver disease
por: Liu, Jifeng, et al.
Publicado: (2023)

Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease
por: Sharpton, Suzanne R., et al.
Publicado: (2018)

Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A
por: Zhang, Mingliang, et al.
Publicado: (2021)

Health-related quality of life in type-2 diabetes patients: a cross-sectional study in East China
por: Lu, You, et al.
Publicado: (2017)

Mammalian Mucosal α-Glucosidases Coordinate with α-Amylase in the Initial Starch Hydrolysis Stage to Have a Role in Starch Digestion beyond Glucogenesis
por: Dhital, Sushil, et al.
Publicado: (2013)

Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
por: Zhou, Tingting, et al.
Publicado: (2023)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
por: Yuan, Xinlu, et al.
Publicado: (2015)

Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease
por: Simpson, Joy, et al.
Publicado: (2016)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_67b4qfl2qkb92bsi7eg32h0aev